Diversified Enterprises’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Diversified Enterprises's GILD Position: Q3 2026 in Review
Diversified Enterprises reduced its Gilead Sciences (GILD) stake by 5.2% in Q3 2026, selling an estimated $22.2K and leaving 2,901 shares worth $432K. The position accounts for 0.02% of the portfolio, ranked #292.
Diversified Enterprises first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. The position peaked at $444K in Q1 2026. 2,341 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Diversified Enterprises held 2,901 shares of Gilead Sciences worth $432K as of Q3 2026.
- Diversified Enterprises sold 158 Gilead Sciences shares in Q3 2026, an estimated $22.2K.
- Gilead Sciences made up 0.02% of Diversified Enterprises's portfolio in Q3 2026, its #292 holding.
- Diversified Enterprises first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
- Diversified Enterprises's Gilead Sciences position peaked at $444K in Q1 2026.
- 2,341 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Diversified Enterprises's 13F filing for Q3 2026, filed 19 Oct 2026.